Globeflex Capital L P Purchases New Position in Encompass Health Corporation $EHC

Globeflex Capital L P acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the second quarter, HoldingsChannel.com reports. The firm acquired 11,065 shares of the company’s stock, valued at approximately $1,118,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of EHC. Persistent Asset Partners Ltd purchased a new stake in Encompass Health during the 2nd quarter valued at $36,000. Keating Financial Advisory Services Inc. purchased a new stake in shares of Encompass Health in the second quarter valued at $39,000. Assetmark Inc. lifted its holdings in shares of Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after acquiring an additional 215 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of Encompass Health during the 4th quarter worth about $55,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $120.94 on Tuesday. The firm has a 50 day moving average of $111.44 and a 200 day moving average of $106.66. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $11.93 billion, a price-to-earnings ratio of 19.70, a price-to-earnings-growth ratio of 2.43 and a beta of 0.72. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, sell-side analysts predict that Encompass Health Corporation will post 6.09 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 0.7%. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health’s payout ratio is presently 12.38%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the transaction, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,451,413.95. The trade was a 10.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on EHC shares. Leerink Partners set a $152.00 price objective on Encompass Health in a research report on Friday, May 22nd. Barclays increased their price target on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Weiss Ratings upgraded Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 12th. TD Cowen lifted their price objective on Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a report on Monday, August 10th. Finally, UBS Group upped their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Encompass Health presently has an average rating of “Buy” and an average price target of $148.71.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.